Novel approaches in myelofibrosis von Koschmieder, Steffen

Volltext

The Approach to Thrombosis Prevention across the Spectrum of Philadelphia-Negative Classic Myeloproliferative Neoplasms von Koschmieder, Steffen

Volltext

Dexamethasone nanomedicines for COVID-19 von Lammers, Twan, Sofias, Alexandros Marios, van der Meel, Roy, Schiffelers, Raymond, Storm, Gert, Tacke, Frank, Koschmieder, Steffen, Brümmendorf, Tim H., Kiessling, Fabian, Metselaar, Josbert M.

Volltext

Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet von Barbui, Tiziano, Tefferi, Ayalew, Vannucchi, Alessandro M., Passamonti, Francesco, Silver, Richard T., Hoffman, Ronald, Verstovsek, Srdan, Mesa, Ruben, Kiladjian, Jean-Jacques, Hehlmann, Rȕdiger, Reiter, Andreas, Cervantes, Francisco, Harrison, Claire, Mc Mullin, Mary Frances, Hasselbalch, Hans Carl, Koschmieder, Steffen, Marchetti, Monia, Bacigalupo, Andrea, Finazzi, Guido, Kroeger, Nicolaus, Griesshammer, Martin, Birgegard, Gunnar, Barosi, Giovanni

Volltext

Kindlin-3 loss curbs chronic myeloid leukemia in mice by mobilizing leukemic stem cells from protective bone marrow niches von Krenn, Peter William, Koschmieder, Steffen, Fässler, Reinhard

Volltext

The Long Noncoding MALAT-1 RNA Indicates a Poor Prognosis in Non-small Cell Lung Cancer and Induces Migration and Tumor Growth von Schmidt, Lars Henning, Spieker, Tilmann, Koschmieder, Steffen, Humberg, Julia, Jungen, Dominik, Bulk, Etmar, Hascher, Antje, Wittmer, Danielle, Marra, Alessandro, Hillejan, Ludger, Wiebe, Karsten, Berdel, Wolfgang E., Wiewrodt, Rainer, Muller-Tidow, Carsten

Volltext

Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients von He, Liye, Tang, Jing, Andersson, Emma I, Timonen, Sanna, Koschmieder, Steffen, Wennerberg, Krister, Mustjoki, Satu, Aittokallio, Tero

Volltext

JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms von Schönberg, Kathrin, Rudolph, Janna, Vonnahme, Maria, Parampalli Yajnanarayana, Sowmya, Cornez, Isabelle, Hejazi, Maryam, Manser, Angela R, Uhrberg, Markus, Verbeek, Walter, Koschmieder, Steffen, Brümmendorf, Tim H, Brossart, Peter, Heine, Annkristin, Wolf, Dominik

Volltext

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib von Barbui, Tiziano, Vannucchi, Alessandro Maria, Alvarez-Larran, Alberto, Iurlo, Alessandra, Masciulli, Arianna, Carobbio, Alessandra, Ghirardi, Arianna, Ferrari, Alberto, Rossi, Giuseppe, Elli, Elena, Andrade-Campos, Marcio Miguel, Kabat, Mercedes Gasior, Kiladjian, Jean-Jaques, Palandri, Francesca, Benevolo, Giulia, Garcia-Gutierrez, Valentin, Fox, Maria Laura, Foncillas, Maria Angeles, Morcillo, Carmen Montoya, Rumi, Elisa, Osorio, Santiago, Papadopoulos, Petros, Bonifacio, Massimiliano, Cervantes, Keina Susana Quiroz, Serrano, Miguel Sagues, Carreno-Tarragona, Gonzalo, Sobas, Marta Anna, Lunghi, Francesca, Patriarca, Andrea, Elorza, Begona Navas, Angona, Anna, Mazo, Elena Magro, Koschmieder, Steffen, Ruggeri, Marco, Cuevas, Beatriz, Hernandez-Boluda, Juan Carlos, Abadia, Emma Lopez, Cirici, Blanca Xicoy, Guglielmelli, Paola, Garrote, Marta, Cattaneo, Daniele, Daffini, Rosa, Cavalca, Fabrizio, Bellosillo, Beatriz, Benajiba, Lina, Curto-Garcia, Natalia, Bellini, Marta, Betti, Silvia, De Stefano, Valerio, Harrison, Claire, Rambaldi, Alessandro

Volltext

Dysregulation of the C/EBPα Differentiation Pathway in Human Cancer von KOSCHMIEDER, Steffen, HALMOS, Balazs, LEVANTINI, Elena, TENEN, Daniel G

Volltext

Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms von Baumeister, Julian, Chatain, Nicolas, Hubrich, Annika, Maié, Tiago, Costa, Ivan G., Denecke, Bernd, Han, Lijuan, Küstermann, Caroline, Sontag, Stephanie, Seré, Kristin, Strathmann, Klaus, Zenke, Martin, Schuppert, Andreas, Brümmendorf, Tim H., Kranc, Kamil R., Koschmieder, Steffen, Gezer, Deniz

Volltext

Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients von Barbui, Tiziano, De Stefano, Valerio, Carobbio, Alessandra, Iurlo, Alessandra, Alvarez-Larran, Alberto, Cuevas, Beatriz, Ferrer Marín, Francisca, Vannucchi, Alessandro M., Palandri, Francesca, Harrison, Claire, Sibai, Hassan, Griesshammer, Martin, Bonifacio, Massimiliano, Elli, Elena M., Trotti, Chiara, Koschmieder, Steffen, Carli, Giuseppe, Benevolo, Giulia, Ianotto, Jean-Christophe, Goel, Swati, Falanga, Anna, Betti, Silvia, Cattaneo, Daniele, Arellano-Rodrigo, Eduardo, Mannelli, Lara, Vianelli, Nicola, Doyle, Andrew, Gupta, Vikas, Wille, Kai, Tremblay, Douglas, Mascarenhas, John

Volltext

Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives von Baumeister, Julian, Chatain, Nicolas, Sofias, Alexandros Marios, Lammers, Twan, Koschmieder, Steffen

Volltext

Inflammatory Responses of Astrocytes Are Independent from Lipocalin 2 von Gasterich, Natalie, Wetz, Sophie, Tillmann, Stefan, Fein, Lena, Seifert, Anke, Slowik, Alexander, Weiskirchen, Ralf, Zendedel, Adib, Ludwig, Andreas, Koschmieder, Steffen, Beyer, Cordian, Clarner, Tim

Volltext

The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey von Harrison, Claire N., Koschmieder, Steffen, Foltz, Lynda, Guglielmelli, Paola, Flindt, Tina, Koehler, Michael, Mathias, Jonathan, Komatsu, Norio, Boothroyd, Robert N., Spierer, Amber, Perez Ronco, Julian, Taylor-Stokes, Gavin, Waller, John, Mesa, Ruben A.

Volltext

Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes von Krug, Utz, Dr, Röllig, Christoph, MD, Koschmieder, Anja, Heinecke, Achim, PhD, Sauerland, Maria Cristina, MSc, Schaich, Markus, Prof, Thiede, Christian, Prof, Kramer, Michael, Braess, Jan, Prof, Spiekermann, Karsten, MD, Haferlach, Torsten, Prof, Haferlach, Claudia, MD, Koschmieder, Steffen, MD, Rohde, Christian, PhD, Serve, Hubert, Prof, Wörmann, Bernhard, Prof, Hiddemann, Wolfgang, Prof, Ehninger, Gerhard, Prof, Berdel, Wolfgang E, Prof, Büchner, Thomas, Prof, Müller-Tidow, Carsten, Prof

Volltext

Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms von Nieborowska-Skorska, Margaret, Maifrede, Silvia, Dasgupta, Yashodhara, Sullivan, Katherine, Flis, Sylwia, Le, Bac Viet, Solecka, Martyna, Belyaeva, Elizaveta A., Kubovcakova, Lucia, Nawrocki, Morgan, Kirschner, Martin, Zhao, Huaqing, Prchal, Josef T., Piwocka, Katarzyna, Moliterno, Alison R., Wasik, Mariusz, Koschmieder, Steffen, Green, Tony R., Skoda, Radek C., Skorski, Tomasz

Volltext

Stem cell persistence in CML is mediated by extrinsically activated JAK1-STAT3 signaling von Kuepper, Maja Kim, Bütow, Marlena, Herrmann, Oliver, Ziemons, Janine, Chatain, Nicolas, Maurer, Angela, Kirschner, Martin, Maié, Tiago, Costa, Ivan G., Eschweiler, Jörg, Koschmieder, Steffen, Brümmendorf, Tim H., Müller-Newen, Gerhard, Schemionek, Mirle

Volltext

Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms von Holl, Kristin, Chatain, Nicolas, Krapp, Susanne, Baumeister, Julian, Maié, Tiago, Schmitz, Sarah, Scheufen, Anja, Brock, Nathalie, Koschmieder, Steffen, Moreno-Andrés, Daniel

Volltext

Is Treatment for Cytopenic Myelofibrosis Still an Unmet Clinical Need? von Caduc, Madeline J., Koschmieder, Steffen

Volltext